This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Vinorelbine + doxorubicin vs doxorubicin: QOL no different in breast cancer. Pharmacoecon. Outcomes News 275, 10 (2000). https://doi.org/10.1007/BF03267333
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03267333